Clinical Trial Update: A 2 Period Cross-over Pharmacokinetic Study of SB204 in Acne Vulgaris [Phase 1]

View source ↗

Summary

A Phase 1 two-period crossover pharmacokinetic study of SB204 in acne vulgaris is reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• SB204

Snippet

Sponsor: Novan, Inc. | Conditions: Acne Vulgaris | Phase 1 | Status: COMPLETED